News
In a report released today, from Macquarie maintained a Buy rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh, with a price target of A$45.90. The company’s shares ...
In a report released today, Andrew Paine from CLSA maintained a Buy rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh, with a price target of A$44.50. The company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback